Language Translation
  Close Menu

Botulism

Botulism (“BOT-choo-liz-um”) is a rare but serious illness caused by a toxin that attacks the body’s nerves and causes difficulty breathing, muscle paralysis, and even death. This toxin is made by Clostridium botulinum and sometimes Clostridium butyricum and Clostridium baratii bacteria. These bacteria can be spread by food and sometimes by other means.


Information for Health Care Providers

If there is a suspected case of botulism, each scenario may be different. Suspect botulism responses should be initiated immediately to avoid serious outcomes, including death. Do not wait for laboratory confirmation to initiate consultation or treatment. Shown below are the general rules for Indiana, as well as who to contact and next steps, depending on what is needed.

  • Botulism is immediately reportable upon suspicion per 410 IAC 1-2.5-75 & 76​
  • First reports SHOULD NOT be through NBS​
  • Please call to report!
  • We cannot do rule-out testing for botulism. If we’re testing, we’re treating​.
  • Decision to treat is based on clinical presentation and is made by the physician, along with IDOH and CDC​
  • IDOH and CDC need to authorize release of antitoxin should a patient truly need it.
Contact TypeName Phone Number
Indiana Department of Health Enteric Epidemiologist
Epi on Call (After Hours) 
(317) 233-7125
(317) 233-1325 
Non-Infant Patients CDC Emergency Operations Center (770) 488-7100
Infant Patients California Department of Health Infant Botulism Treatment and Prevention Program (510) 231-7600

Botulism Treatment Logistics

Botulism Treatment Logistics

Botulism Anti-Toxin (Non-Infant Patients)

Once consultation and approval are appropriately discussed between CDC, IDOH, and the provider, CDC will release the antitoxin from the nearest Quarantine Station (Chicago). CDC will then help coordinate with the given facility and the quarantine station for proper shipment and administration.

CDC produced a video to guide healthcare professionals through preparing and administering antitoxin to treat botulism. The video also answers some questions often asked during clinical consultations for suspect botulism cases. As a companion to the antitoxin’s FDA package insert, the video can prepare patient care teams to act when the antitoxin arrives. If a large botulism outbreak occurs, public health officials and first responders may also turn to the video for guidance.

BabyBIG (infant patients)

Once consultation and agreement for the release of BabyBIG is agreed between California Department of Health and the calling provider, California will organize the transfer of BabyBIG to the given facility.

Testing for botulism is the same for any type of botulism. To have botulism tested, botulism anti-toxin or BabyBIG are required to be given. In Indiana, testing is performed in Ohio, however samples are still required to be sent to the Indiana Department of Health Laboratory. The Ohio tests include mouse bioassay, polymerase chain reaction (PCR), and culture. Testing can vary in time from nine days for a negative result and 17 days for a positive result. IDOH personnel will update all parties involved as soon as possible when results are shared from Ohio.

To collect specimens, it is best practice to have it collected prior to administration of anti-toxin/BabyBIG. Traditionally, botulism is tested in stool specimens or blood, but if other specimens are requested, please consult with the Indiana Department of Health. See attached for more specific requirements for testing. For samples to be thoroughly processed, without delay, please also fill out the Microbiology Specimen Submission Form from Ohio.

Samples are to be sent initially to the Indiana Department of Health Laboratory, addressed to the Biological Preparedness division (see below for shipping specifics). For specimens sent to IDOHL, please also submit it in LimsNET.

ATTN: Biothreat Laboratory
550 W. 16th St, Suite B
Indianapolis, IN 46202
CLIA 15D0662599

Samples are to be sent initially to the Indiana Department of Health Laboratory, addressed to the Biological Preparedness division (see below for shipping specifics). For specimens sent to IDOHL, please also submit it in LimsNET.

ATTN: Biothreat Laboratory
550 W. 16th St, Suite B
Indianapolis, IN 46202
CLIA 15D0662599

Page last updated/reviewed: November 2024